Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)
USD 2.16
(0.46%)
USD 2.16
(0.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.26 Billion CNY | 16.5% |
| 2022 | 1.1 Billion CNY | 16.79% |
| 2021 | 991.27 Million CNY | 13.7% |
| 2020 | 878.91 Million CNY | 3.71% |
| 2019 | 846.18 Million CNY | 17.06% |
| 2018 | 728.15 Million CNY | 13.24% |
| 2017 | 403.77 Million CNY | 5.6% |
| 2016 | 553.13 Million CNY | -10.19% |
| 2015 | 640.06 Million CNY | 17.96% |
| 2014 | 563.16 Million CNY | 5.54% |
| 2013 | 434.93 Million CNY | -20.09% |
| 2012 | 661.1 Million CNY | 51.16% |
| 2011 | 427.91 Million CNY | -9.81% |
| 2010 | 492.14 Million CNY | 85.44% |
| 2009 | 269.95 Million CNY | -23.33% |
| 2008 | 345.6 Million CNY | 29.41% |
| 2007 | 93.23 Million CNY | 234.86% |
| 2006 | -208.63 Million CNY | -170.64% |
| 2005 | 282.92 Million CNY | 18.83% |
| 2004 | 238.08 Million CNY | 8.31% |
| 2003 | 219.82 Million CNY | 21.85% |
| 2002 | 180.41 Million CNY | 14.65% |
| 2001 | 156.2 Million CNY | 41.2% |
| 2000 | 111.44 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 187.5 Million CNY | -41.07% |
| 2024 Q2 | 335.1 Million CNY | -28.88% |
| 2024 Q1 | 454.91 Million CNY | 214.82% |
| 2023 FY | - CNY | 16.5% |
| 2023 Q3 | 181.56 Million CNY | -51.35% |
| 2023 Q4 | 203.42 Million CNY | 12.04% |
| 2023 Q1 | 468.03 Million CNY | 165.64% |
| 2023 Q2 | 373.2 Million CNY | -20.26% |
| 2022 FY | - CNY | 16.79% |
| 2022 Q1 | 201.58 Million CNY | 123.14% |
| 2022 Q4 | 176.19 Million CNY | -42.52% |
| 2022 Q3 | 306.51 Million CNY | -15.67% |
| 2022 Q2 | 363.45 Million CNY | 80.3% |
| 2021 Q3 | 378.26 Million CNY | 75.08% |
| 2021 FY | - CNY | 13.7% |
| 2021 Q4 | 90.33 Million CNY | -76.12% |
| 2021 Q1 | 196.71 Million CNY | -38.8% |
| 2021 Q2 | 216.04 Million CNY | 9.83% |
| 2020 Q2 | 236.85 Million CNY | 54.43% |
| 2020 Q1 | 153.37 Million CNY | -29.3% |
| 2020 Q3 | 136.44 Million CNY | -42.39% |
| 2020 FY | - CNY | 3.71% |
| 2020 Q4 | 321.43 Million CNY | 135.58% |
| 2019 Q2 | 176.39 Million CNY | -12.43% |
| 2019 FY | - CNY | 17.06% |
| 2019 Q3 | 152.53 Million CNY | -13.53% |
| 2019 Q4 | 216.93 Million CNY | 42.22% |
| 2019 Q1 | 201.44 Million CNY | 4.03% |
| 2018 Q3 | 104.64 Million CNY | -56.6% |
| 2018 FY | - CNY | 13.24% |
| 2018 Q4 | 193.63 Million CNY | 85.04% |
| 2018 Q2 | 241.12 Million CNY | 125.99% |
| 2018 Q1 | 106.69 Million CNY | -65.51% |
| 2017 Q4 | 309.31 Million CNY | 300.59% |
| 2017 FY | - CNY | 5.6% |
| 2017 Q1 | 97.5 Million CNY | -64.52% |
| 2017 Q2 | 212.38 Million CNY | 117.83% |
| 2017 Q3 | 77.21 Million CNY | -63.64% |
| 2016 Q2 | 211.5 Million CNY | 134.96% |
| 2016 Q3 | 62.26 Million CNY | -70.56% |
| 2016 FY | - CNY | -10.19% |
| 2016 Q4 | 274.77 Million CNY | 341.31% |
| 2016 Q1 | 90.01 Million CNY | -69.98% |
| 2015 Q2 | 192.39 Million CNY | 60.64% |
| 2015 Q1 | 119.76 Million CNY | -35.88% |
| 2015 Q3 | 44.02 Million CNY | -77.12% |
| 2015 Q4 | 299.82 Million CNY | 581.08% |
| 2015 FY | - CNY | 17.96% |
| 2014 FY | - CNY | 5.54% |
| 2014 Q1 | 119.78 Million CNY | -33.52% |
| 2014 Q2 | 154.59 Million CNY | 29.06% |
| 2014 Q3 | 58.39 Million CNY | -62.23% |
| 2014 Q4 | 186.77 Million CNY | 219.85% |
| 2013 FY | - CNY | -20.09% |
| 2013 Q3 | 53.94 Million CNY | -56.2% |
| 2013 Q4 | 180.19 Million CNY | 234.05% |
| 2013 Q2 | 123.14 Million CNY | -7.1% |
| 2013 Q1 | 132.55 Million CNY | -57.17% |
| 2012 FY | - CNY | 51.16% |
| 2012 Q4 | 309.47 Million CNY | 474.33% |
| 2012 Q3 | 53.88 Million CNY | -82.09% |
| 2012 Q2 | 300.9 Million CNY | 143.47% |
| 2012 Q1 | 123.59 Million CNY | 18.82% |
| 2011 Q4 | 104.01 Million CNY | 100.48% |
| 2011 Q1 | 117.89 Million CNY | -35.4% |
| 2011 Q3 | 51.88 Million CNY | -56.11% |
| 2011 Q2 | 118.21 Million CNY | 0.27% |
| 2011 FY | - CNY | -9.81% |
| 2010 Q4 | 182.5 Million CNY | 448.48% |
| 2010 Q3 | 33.27 Million CNY | -64.41% |
| 2010 Q2 | 93.48 Million CNY | 3.11% |
| 2010 Q1 | 90.66 Million CNY | 571.97% |
| 2010 FY | - CNY | 85.44% |
| 2009 FY | - CNY | -23.33% |
| 2009 Q4 | 13.49 Million CNY | -47.11% |
| 2009 Q1 | 76.11 Million CNY | -41.21% |
| 2009 Q2 | 98.78 Million CNY | 29.78% |
| 2009 Q3 | 25.51 Million CNY | -74.17% |
| 2008 FY | - CNY | 29.41% |
| 2008 Q4 | 129.47 Million CNY | 339.3% |
| 2008 Q3 | 29.47 Million CNY | -78.6% |
| 2008 Q2 | 137.72 Million CNY | 188.03% |
| 2008 Q1 | 47.81 Million CNY | -65.95% |
| 2007 FY | - CNY | 234.86% |
| 2007 Q4 | 140.42 Million CNY | 1305.59% |
| 2007 Q3 | -11.64 Million CNY | -108.1% |
| 2007 Q2 | 143.75 Million CNY | 284.79% |
| 2007 Q1 | 37.36 Million CNY | 112.88% |
| 2006 Q3 | 13.18 Million CNY | -88.05% |
| 2006 FY | - CNY | -170.64% |
| 2006 Q2 | 110.29 Million CNY | 403.8% |
| 2006 Q4 | -290.03 Million CNY | -2300.1% |
| 2006 Q1 | 21.89 Million CNY | -86.33% |
| 2005 Q4 | 160.12 Million CNY | 352.58% |
| 2005 Q3 | 35.38 Million CNY | -68.33% |
| 2005 Q2 | 111.72 Million CNY | 232.66% |
| 2005 Q1 | 33.58 Million CNY | -72.21% |
| 2005 FY | - CNY | 18.83% |
| 2004 Q4 | 120.84 Million CNY | 282.9% |
| 2004 Q3 | 31.56 Million CNY | -68.77% |
| 2004 FY | - CNY | 8.31% |
| 2004 Q2 | 101.05 Million CNY | 198.41% |
| 2004 Q1 | 33.86 Million CNY | -70.1% |
| 2003 FY | - CNY | 21.85% |
| 2003 Q4 | 113.27 Million CNY | 595.66% |
| 2003 Q2 | 73.45 Million CNY | 89.97% |
| 2003 Q1 | 38.66 Million CNY | -41.67% |
| 2003 Q3 | 16.28 Million CNY | -77.83% |
| 2002 Q4 | 66.28 Million CNY | 528.2% |
| 2002 Q1 | 17.17 Million CNY | 0.0% |
| 2002 Q3 | -15.48 Million CNY | -126.94% |
| 2002 Q2 | 57.45 Million CNY | 234.56% |
| 2002 FY | - CNY | 14.65% |
| 2001 FY | - CNY | 41.2% |
| 2000 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|